Correlation Between JPMorgan Chase and Medicenna Therapeutics
Can any of the company-specific risk be diversified away by investing in both JPMorgan Chase and Medicenna Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining JPMorgan Chase and Medicenna Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between JPMorgan Chase Co and Medicenna Therapeutics Corp, you can compare the effects of market volatilities on JPMorgan Chase and Medicenna Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in JPMorgan Chase with a short position of Medicenna Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of JPMorgan Chase and Medicenna Therapeutics.
Diversification Opportunities for JPMorgan Chase and Medicenna Therapeutics
-0.46 | Correlation Coefficient |
Very good diversification
The 3 months correlation between JPMorgan and Medicenna is -0.46. Overlapping area represents the amount of risk that can be diversified away by holding JPMorgan Chase Co and Medicenna Therapeutics Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Medicenna Therapeutics and JPMorgan Chase is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on JPMorgan Chase Co are associated (or correlated) with Medicenna Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Medicenna Therapeutics has no effect on the direction of JPMorgan Chase i.e., JPMorgan Chase and Medicenna Therapeutics go up and down completely randomly.
Pair Corralation between JPMorgan Chase and Medicenna Therapeutics
Assuming the 90 days trading horizon JPMorgan Chase Co is expected to generate 0.44 times more return on investment than Medicenna Therapeutics. However, JPMorgan Chase Co is 2.3 times less risky than Medicenna Therapeutics. It trades about 0.2 of its potential returns per unit of risk. Medicenna Therapeutics Corp is currently generating about -0.23 per unit of risk. If you would invest 2,921 in JPMorgan Chase Co on September 4, 2024 and sell it today you would earn a total of 357.00 from holding JPMorgan Chase Co or generate 12.22% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
JPMorgan Chase Co vs. Medicenna Therapeutics Corp
Performance |
| Timeline |
| JPMorgan Chase |
| Medicenna Therapeutics |
JPMorgan Chase and Medicenna Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with JPMorgan Chase and Medicenna Therapeutics
The main advantage of trading using opposite JPMorgan Chase and Medicenna Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if JPMorgan Chase position performs unexpectedly, Medicenna Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Medicenna Therapeutics will offset losses from the drop in Medicenna Therapeutics' long position.| JPMorgan Chase vs. Data Communications Management | JPMorgan Chase vs. Partners Value Investments | JPMorgan Chase vs. CVS HEALTH CDR | JPMorgan Chase vs. 2028 Investment Grade |
| Medicenna Therapeutics vs. Aptose Biosciences | Medicenna Therapeutics vs. Oncolytics Biotech | Medicenna Therapeutics vs. Helix BioPharma Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Other Complementary Tools
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |